Preclinical Imaging Market Size Forecasted To Achieve $4.83 Billion By 2029 With Steady Growth

The Preclinical Imaging Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Preclinical Imaging Market Size and Projected Growth Rate?
In recent years, the preclinical imaging market has shown robust growth. It is poised to expand from $3.46 billion in 2024 to $3.69 billion in 2025, registering a compound annual growth rate (CAGR) of 6.7%. The surge in the previous years is credited to various factors such as government schemes, rising disease incidences, broadening applications, heightened awareness, and growth in emerging markets.

The market size of preclinical imaging is projected to experience significant expansion in the coming years, increasing to $4.83 billion by 2029 with a compound annual growth rate (CAGR) of 6.9%. Factors driving this growth across the forecast period include the uptake of personalized medicine, advances in molecular imaging, the outsourcing of drug development, regulatory assistance, and the prevalence of chronic diseases. Key trends during the forecast period entail eco-friendly imaging technologies, technological progress, an increase in research and development activities, collaborations and partnerships, and real-time imaging.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

What Are the Major Segments in the Preclinical Imaging Market?
The preclinical imaging market covered in this report is segmented -

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Are The Driving Preclinical Imaging Market Evolution?
The advancement of the preclinical imaging market is expected to be driven by the surge in chronic diseases. Chronic ailments are drawn out health conditions that last typically for at least three months or more. They usually necessitate persistent medical oversight and substantially affect an individual's lifestyle. Preclinical imaging techniques are employed to discern these diseases by inspecting bone structures and pulmonary functions. These tools are also used to examine the evolution of chronic diseases, thereby enhancing the understanding of these conditions. For instance, the World Health Organization (WHO) 2022 Highlights stated that in September 2022, chronic or Noncommunicable diseases (NCDs) were responsible for 74% of all deaths globally, registering about 41 million fatalities. Included in these are 17.9 million deaths due to cardiovascular diseases, 9.3 million resulting from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the escalating number of chronic diseases is propelling the preclinical imaging market's expansion.

Which Firms Dominate The Preclinical Imaging Market Segments?
Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

What Trends Are Expected to Dominate the Preclinical Imaging Market in the Next 5 Years?
In the preclinical imaging market, a primary trend that is garnering attention is the introduction of innovative products. To maintain their market foothold, leading corporations in the preclinical imaging market are producing a slew of novel products. As a case in point, Fujifilm VisualSonics Inc., a leading biomedical company in Canada that manufactures imaging systems, announced the release of the Vevo F2, their latest preclinical imaging system, in May 2022. The Vevo F2, notable for being the initial preclinical imaging system capable of ultra-high to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging, boasts collective features like HD image processing technology, a completely revamped signal pathway, bespoke system architecture, a wide spectrum of anatomical targets, and high-resolution imaging. This not only guarantees improved image clarity and superior frame rates but also makes it adaptable to the exact precision requirements of imaging. This new product is appropriate for a broad range of research applications.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Is The Largest Region In The Preclinical Imaging Market?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Preclinical Imaging Market?
2. What is the CAGR expected in the Preclinical Imaging Market?
3. What Are the Key Innovations Transforming the Preclinical Imaging Industry?
4. Which Region Is Leading the Preclinical Imaging Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.